NasdaqGS - Nasdaq Real Time Price USD
Arcellx, Inc. (ACLX)
52.94
+0.14
+(0.27%)
At close: May 7 at 4:00:00 PM EDT
52.76
-0.18
(-0.34%)
After hours: May 7 at 6:29:03 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 13 | 12 |
| Avg. Estimate | -0.74 | -0.77 | -3.02 | -2.52 |
| Low Estimate | -1.09 | -1.14 | -4.39 | -5.01 |
| High Estimate | -0.63 | -0.64 | -1.87 | 1.53 |
| Year Ago EPS | -0.14 | -0.51 | -2 | -3.02 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 9 | 9 | 16 | 14 |
| Avg. Estimate | 19.51M | 19.47M | 89.19M | 178.41M |
| Low Estimate | 14.9M | 14.9M | 20M | 80.9M |
| High Estimate | 26M | 26M | 143M | 309.72M |
| Year Ago Sales | 39.26M | 27.38M | 107.94M | 89.19M |
| Sales Growth (year/est) | -50.30% | -28.89% | -17.37% | 100.04% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.46 | -0.5 | -0.24 | -0.47 |
| EPS Actual | -0.14 | -0.51 | -0.48 | -0.87 |
| Difference | 0.32 | -0.01 | -0.24 | -0.4 |
| Surprise % | 69.51% | -1.96% | -96.20% | -83.40% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.74 | -0.77 | -3.02 | -2.52 |
| 7 Days Ago | -0.74 | -0.77 | -3.02 | -2.52 |
| 30 Days Ago | -0.76 | -0.79 | -3.1 | -2.55 |
| 60 Days Ago | -0.7 | -0.76 | -2.24 | -2.93 |
| 90 Days Ago | -0.7 | -0.76 | -2.24 | -2.93 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 2 | 2 | -- | -- |
| Up Last 30 Days | 2 | 2 | 2 | 3 |
| Down Last 7 Days | 1 | 1 | 1 | 1 |
| Down Last 30 Days | 1 | 1 | 11 | 4 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ACLX | -427.62% | -50.48% | -51.13% | 16.64% |
| S&P 500 | 12.50% | 3.24% | 7.95% | 13.84% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 12/10/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/10/2024 |
| Reiterates | Needham: Buy to Buy | 12/10/2024 |
| Reiterates | Needham: Buy to Buy | 12/9/2024 |
| Maintains | Truist Securities: Buy to Buy | 11/12/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/8/2024 |
Related Tickers
RNA Avidity Biosciences, Inc.
26.17
-0.34%
PCVX Vaxcyte, Inc.
29.00
-0.82%
KRYS Krystal Biotech, Inc.
136.80
-1.91%
NUVL Nuvalent, Inc.
66.72
-2.16%
LEGN Legend Biotech Corporation
31.47
+0.32%
CYTK Cytokinetics, Incorporated
33.04
-2.74%
PTCT PTC Therapeutics, Inc.
40.76
+12.63%
RARE Ultragenyx Pharmaceutical Inc.
33.42
-4.68%
APGE Apogee Therapeutics, Inc.
35.24
-0.93%
AKRO Akero Therapeutics, Inc.
42.79
+1.83%